III. Albendazole in the treatment of inoperable hydatid disease in Kenya—a report on 12 cases

dc.contributor.author	Okelo, GBA
dc.date.accessioned	2013-06-30T09:25:14Z
dc.date.available	2013-06-30T09:25:14Z
dc.date.issued	1986
dc.identifier.citation	Transactions of the Royal Society of Tropical Medicine and Hygiene Volume 80, Issue 2, 1986, Pages 193–195	en
dc.identifier.uri	http://www.sciencedirect.com/science/article/pii/0035920386900052
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/42815
dc.description.abstract	The results of treatment of 12 cases of inoperable hydatid disease in Kenya using albendazole at a dose of 10 mg/kg body-weight for eight weeks are reported. In all the cases there was marked regression and collapse of the cysts but a further four weeks course of treatment at a higher dose of 15 mg/kg was given to two cases because they both still had a large number of demonstrable cysts on ultrasonography at eight weeks. No side effects of the drug were noted. Albendazole is likely to play an important role in the control programme in Turkana.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	III. Albendazole in the treatment of inoperable hydatid disease in Kenya—a report on 12 cases	en
dc.type	Article	en
local.publisher	Department of Medicine	en